Sumitomo Life Insurance Co. Takes $1.56 Million Position in CVS Health Corporation $CVS

Key Points

• Sumitomo Life Insurance acquired 15,126 CVS Health shares in the second quarter, valued at approximately $1.56 million. Several other institutional investors also initiated positions, and institutions collectively own 80.66% of the company.
• Analysts remain broadly positive, with 22 Buy ratings and two Holds. CVS has a consensus “Moderate Buy” rating and an average price target of $107.17.
• CVS reported quarterly earnings of $2.58 per share, exceeding estimates of $1.87, while revenue rose 7.3% year over year to $106.10 billion. The company also maintains a quarterly dividend of $0.665 per share, equivalent to a 2.9% annual yield.

Sumitomo Life Insurance Co. acquired a new position in CVS Health Corporation (NYSE:CVS - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 15,126 shares of the pharmacy operator's stock, valued at approximately $1,565,000.

A number of other large investors have also recently bought and sold shares of the company. Landscape Capital Management L.L.C. acquired a new position in CVS Health in the 2nd quarter worth approximately $8,515,000. Korea Investment CORP acquired a new stake in CVS Health during the 2nd quarter valued at approximately $97,590,000. EP Wealth Advisors LLC purchased a new stake in shares of CVS Health in the 2nd quarter valued at $7,711,000. Ieq Capital LLC acquired a new stake in shares of CVS Health in the second quarter worth $20,047,000. Finally, Callan Family Office LLC acquired a new stake in shares of CVS Health in the second quarter worth $17,069,000. Hedge funds and other institutional investors own 80.66% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on CVS shares. Argus boosted their target price on shares of CVS Health from $104.00 to $114.00 and gave the company a "buy" rating in a research report on Wednesday. DA Davidson increased their price target on CVS Health from $80.00 to $100.00 and gave the stock a "buy" rating in a research report on Thursday, May 7th. Cantor Fitzgerald lifted their price objective on CVS Health from $100.00 to $110.00 and gave the company an "overweight" rating in a research note on Tuesday, July 7th. Piper Sandler reissued an "overweight" rating and issued a $113.00 price objective on shares of CVS Health in a report on Monday, June 1st. Finally, Morgan Stanley raised their target price on CVS Health from $106.00 to $111.00 and gave the stock an "overweight" rating in a report on Thursday, June 4th. Twenty-two equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $107.17.

CVS Health Stock Performance

CVS opened at $93.01 on Friday. The firm has a fifty day moving average price of $102.02 and a 200 day moving average price of $88.86. CVS Health Corporation has a 1 year low of $69.51 and a 1 year high of $110.68. The stock has a market cap of $118.96 billion, a P/E ratio of 24.61, a P/E/G ratio of 0.85 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.87 and a quick ratio of 0.66.

CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings data on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share for the quarter, beating analysts' consensus estimates of $1.87 by $0.71. The company had revenue of $106.10 billion during the quarter, compared to analysts' expectations of $100.03 billion. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The firm's revenue for the quarter was up 7.3% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.81 earnings per share. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Equities research analysts anticipate that CVS Health Corporation will post 8.02 earnings per share for the current year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, August 3rd. Stockholders of record on Thursday, July 23rd were given a $0.665 dividend. The ex-dividend date was Thursday, July 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 2.9%. CVS Health's payout ratio is 70.37%.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source